Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
Horizons Enhanced NASDAQ-100 Covered Call ETF declares CAD 0.25 dividend
Post Content Post Views: 118
URA Holdings raises £1 million for Gravellotte mine revival
Post Content Post Views: 141
Australia CPI inflation eases more than expected in Oct, but remains sticky
Post Content Post Views: 111
Ex-Binance CEO Zhao urges judge to allow him to leave the U.S. before sentencing
U.S. authorities said Binance broke U.S. anti-money laundering and sanctions laws. Post Views: 128
US aircraft carrier Carl Vinson arrives in South Korea port
Post Content Post Views: 125
U.S. bank profits slow on lower noninterest income, higher realized losses
Post Content Post Views: 112